OpenAlex
PricingAboutJobs
Log inGet started
Work

Galantamine Provides Broad Benefits in Patients With ‘advanced Moderate’ Alzheimer's Disease (mmse ≤12) for up to Six Months

HTML

Year: 2002
Type: article
Source: International Journal of Clinical Practice
DOI: 10.1111/j.1742-1241.2002.tb11310.x
Authors: DG Wilkinson, C Hock, M Farlow, B Van Baelen, S Schwalen
Institutions: Moorgreen Hospital, University of Zurich, Indiana University School of Medicine, Janssen (Germany)
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: galantamine, Alzheimer's disease, cholinergic drugs, cognitive function, functional capacity, behavioural symptoms, post hoc analysis, Mini-Mental State Examination, ADAS-Cog
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4367473664
FWCI: 4.195
Cites: 17
Cited by: 48
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms